autoimmune disease
FDA Approves Saphnelo, First New Treatment for Lupus in 10 Years
This marks the first regulatory approval for a type I interferon receptor antagonist, which plays a central role in ...
AUGUST 4, 2021
FDA Approves Abrilada, Biosimilar to Humira
This approval marks the 25th biosimilar approved in the United States, but only a handful are currently available. ...
NOVEMBER 21, 2019
Neuromodulation Shown Potentially Safe, Effective for Rheumatoid Arthritis
A new bioelectronic medicine approach to treat autoimmune diseases using vagus nerve stimulation (VNS) demonstrated ...
APRIL 18, 2019
Load more